| Title |
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers
|
|---|---|
| Published in |
JAMA Internal Medicine, February 2021
|
| DOI | 10.1001/jamainternmed.2020.6319 |
| Pubmed ID | |
| Authors |
Benjamin S. Abella, Eliana L. Jolkovsky, Barbara T. Biney, Julie E. Uspal, Matthew C. Hyman, Ian Frank, Scott E. Hensley, Saar Gill, Dan T. Vogl, Ivan Maillard, Daria V. Babushok, Alexander C. Huang, Sunita D. Nasta, Jennifer C. Walsh, E. Paul Wiletyo, Phyllis A. Gimotty, Michael C. Milone, Ravi K. Amaravadi |
X Demographics
The data shown below were collected from the profiles of 1,563 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 263 | 17% |
| Brazil | 84 | 5% |
| France | 83 | 5% |
| Chile | 42 | 3% |
| Spain | 41 | 3% |
| Australia | 39 | 2% |
| India | 30 | 2% |
| United Kingdom | 29 | 2% |
| Argentina | 27 | 2% |
| Other | 239 | 15% |
| Unknown | 686 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1224 | 78% |
| Scientists | 184 | 12% |
| Practitioners (doctors, other healthcare professionals) | 118 | 8% |
| Science communicators (journalists, bloggers, editors) | 36 | 2% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 396 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 396 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 44 | 11% |
| Student > Bachelor | 40 | 10% |
| Researcher | 34 | 9% |
| Other | 33 | 8% |
| Student > Doctoral Student | 18 | 5% |
| Other | 77 | 19% |
| Unknown | 150 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 109 | 28% |
| Nursing and Health Professions | 26 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 17 | 4% |
| Biochemistry, Genetics and Molecular Biology | 16 | 4% |
| Agricultural and Biological Sciences | 9 | 2% |
| Other | 48 | 12% |
| Unknown | 171 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1651. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 March 2024.
All research outputs
#6,673
of 25,744,802 outputs
Outputs from JAMA Internal Medicine
#82
of 11,710 outputs
Outputs of similar age
#343
of 538,081 outputs
Outputs of similar age from JAMA Internal Medicine
#1
of 108 outputs
Altmetric has tracked 25,744,802 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,710 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 85.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 538,081 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.